Skip to main content
OpenTrials
Completed

NCT Number: NCT07564869

Skin Hydration and Facial Aging in Women Aged 30-60: An Observational Correlational Study Using Bioimpedance Analysis

This study investigates whether skin hydration levels are related to how old the skin looks. Thirty women aged 30 to 60 years will attend a single visit at a licensed esthetic practice in Florida. Skin moisture will be measured at seven points on the face using the BT-Analyze device. Photographs will be taken and evaluated by a blinded expert cosmetologist using a standard aging scoring system. The study will determine whether women with lower skin hydration tend to show more visible signs of aging.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–60 year

Sex eligibility

Female

Study type

Observational

Primary location

IAS Skin Care

Winter Garden, Florida, 34787, United States

About this study

Skin hydration is maintained through hyaluronic acid, natural moisturizing factor (NMF), and the lipid barrier of the stratum corneum. Dehydration activates matrix metalloproteinases (MMPs) which degrade collagen and elastin, accelerating visible aging. This cross-sectional observational study will enroll 30 women in three age groups (30-40, 40-50, and 50-60 years). Hydration will be assessed using BT-Analyze across seven facial zones. The primary outcome is the Spearman rank correlation between mean hydration score and modified Glogau visual aging score (0-18 points). Covariates include age, Fitzpatrick skin type, daily water intake, menopausal status, and skincare habits.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Female, aged 30 to 60 years Willing to attend one study visit without makeup No cosmetics applied for at least 4 hours prior to the visit Able to acclimate in controlled indoor environment for 20 minutes Signed written informed consent

Exclusion criteria

Active dermatological conditions (eczema, psoriasis, rosacea in flare) Injectable cosmetic procedures within the past 6 months Systemic medications affecting skin condition (oral retinoids, systemic corticosteroids) Pregnancy or lactation Uncontrolled systemic conditions known to significantly affect skin (e.g., uncontrolled diabetes mellitus)

Treatment and study plan

BT-Analyze Bioimpedance Measurement

Other

Non-invasive skin hydration measurement using BT-Analyze bioimpedance device at seven standardized facial zones. No therapeutic intervention is administered.

Primary outcomes

  1. Spearman Correlation Between BT-Analyze Mean Score and Modified Glogau Visual Aging Score

    Time frame: At single study visit (Day 1)

    Spearman rank correlation coefficient (rs) between mean BT-Analyze hydration score (mean of seven facial zones, 0-65 units) and total modified Glogau visual aging score (0-18 points) assessed by a blinded expert cosmetologist.

Secondary outcomes

  1. BT-Analyze Score Comparison Across Age Groups

    Time frame: At single study visit (Day 1)

    Kruskal-Wallis comparison of mean BT-Analyze hydration scores between three age groups (30-40, 40-50, 50-60 years).

Sponsors and collaborators

Lead sponsor

IAS Skin Care

Industry

Registry information

Official study title

Skin Hydration and Facial Aging: A Cross-Sectional Correlational Observational Study Using BT-Analyze Bioimpedance Assessment Across Seven Facial Zones in Women Aged 30-60 Years

Acronym: SHFA-30-60

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 4, 2026
Registry last updated
Jun 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.